Search for Clinical Trial Results

Sponsored By

Hemangiosarcoma - 13 Studies Found

Status Study
Active, not recruiting Study Name: Bevacizumab in Treating Patients With Angiosarcoma
Condition: Sarcoma
Date: 2006-02-06
Interventions: Biological: Bevacizumab Bevacizumab 15 mg/kg IV infusion given on day 1 every 21 days = (1 cycle).
Active, not recruiting Study Name: A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
Condition: Soft Tissue Sarcoma
Date: 2010-06-08
Interventions: Drug: Axitinib Patients will take axitinib tablets 5 mg by mouth twice daily continuously. There may be
Completed Study Name: Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Condition:
  • Sarcoma
  • Leiomyosarcoma
  • Malignant Fibrous
  • Drug: gemcitabine
  • Drug: docetaxel
<<< Previous